LACE-conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: Treatment Outcome and Risk Factor Analysis in 67 Patients From a Single Centre

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma

Turkish Journal of Medical Sciences
Medicine
2019English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Prognostic Factors and Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation Following a Uniform-Modified BEAM-conditioning Regimen for Patients With Refractory or Relapsed Hodgkin Lymphoma: A Single-Center Experience

Medical Oncology
MedicineCancer ResearchOncologyHematology
2013English

Autologous Stem Cell Transplantation in Elderly (>60 Years) Patients With Non-Hodgkin's Lymphoma: A Nation-Wide Analysis

Bone Marrow Transplantation
TransplantationHematology
2006English

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy